Effect of hyperbaric oxygen on the immunoreactivity to substance P in the nasal mucosa of cluster headache patients | Canada Hyperbarics Skip to main content
Clinical Trial Headache 1996

Effect of hyperbaric oxygen on the immunoreactivity to substance P in the nasal mucosa of cluster headache patients

Di Sabato F, Giacovazzo M, Cristalli G, Rocco M, Fusco B — Headache, 1996

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated how hyperbaric oxygen therapy affects a specific pain-related substance called substance P in the nasal lining of cluster headache patients.

What They Found

Patients treated with hyperbaric oxygen showed a marked and statistically significant decrease in substance P in their nasal mucosa. This reduction was significant when compared to a placebo group, suggesting that HBOT influences peripheral neuropeptides.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study focused on a biological mechanism rather than directly measuring patient symptoms or long-term clinical outcomes.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Trial
Category Uncategorised
Source Pubmed
PubMed ID 8675426
Year Published 1996
Journal Headache
MeSH Terms Adult; Antigen-Antibody Reactions; Cluster Headache; Female; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Nasal Mucosa; Substance P

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology